High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping

Journal of Medical Virology

Volumn 85, Issue 1, 2013, Pages 91-98

  Tanzi, Elisabetta ^a,b   Bianchi, Silvia ^a   Fasolo, Maria Michela ^c   Frati, Elena R ^a   Mazza, Francesca ^c   Martinelli, Marianna ^a   Colzani, Daniela ^a   Beretta, Rosangela ^c   Zappa, Alessandra ^a   Orlando, Giovanna ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

HPV DNA; HPV genotyping; Molecular screening; PCR based assay; Urine testing

Indexed keywords

HEMOGLOBIN BETA CHAIN; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 73; MOLECULAR WEIGHT; OUTPATIENT CARE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEXUAL TRANSMISSION; URINALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; AGED; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; URINE; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; NUCLEOPOLYHEDROVIRUS;

EID: 84869178325     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23434     Document Type: Article

References (35)

1. ACOG Committee on Practice Bulletins-Gynecology. 2009. ACOG Practice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol 144: 1409-1420.
2. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. 1994. Identification and assessment of known and novel Human Papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170: 1077-1085.
3. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
4. Bissett SL, Howell-Jones R, Swift C, De Silva N, Biscornet L, Parry JV, Saunders NA, Nathan M, Soldan K, Szarewski A, Cuzick J, Beddows S. 2011. Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol 83: 1744-1751.
5. Cronjé HS. 2011. Cervical screening strategies in resourced and resource-constrained countries. Best Pract Res Clin Obstet Gynaecol 25: 575-584.
6. Crotchfelt KA, Welsh LE, DeBonville D, Rosenstraus M, Quinn TC. 1997. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol 35: 1536-1540.
7. Cuschieri K, Nandwani R, McGough P, Cook F, Hogg L, Robertson C, Cubie H. 2011. Urine testing as a surveillance tool to monitor the impact of HPV immunization programs. J Med Virol 83: 1983-1987.
8. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. 2006. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119: 1095-1101.
9. D'Hauwers KW, Tjalma WA. 2009. Screening for human papillomavirus: Is urine useful? Indian J Cancer 46: 190-193.
10. Garbuglia AR, Piselli P, Lapa D, Sias C, Del Nonno F, Baiocchini A, Cimaglia C, Agresta A, Capobianchi MR. 2012. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy. J Clin Virol 54: 141-146.
11. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. 2000. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361.
12. Gupta A, Arora R, Gupta S, Prusty BK, Kailash U, Batra S, Das BC. 2006. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens. J Clin Virol 37: 190-194.
13. Hussain S, Bharadwaj M, Nasare V, Kumari M, Sharma S, Hedau S, Das BC. 2012. Human papillomavirus infection among young adolescents in India: Impact of vaccination. J Med Virol 84: 298-305.
14. IARC. 2011. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 100B: 261-319.
15. Igidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M. 2011. Self-collected human papillomavirus testing acceptability: Comparison of two self-sampling modalities. J Womens Health 20: 397-402.
16. Jin XW, Sikon A, Yen-Lieberman B. 2011. Cervical cancer screening: Less testing, smarter testing. Cleve Clin J Med 78: 737-747.
17. Jong E, Mulder JW, van Gorp EC, Wagenaar JK, Derksen J, Westerga J, Tol A, Smits PH. 2008. The prevalence of human papillomavirus (HPV) infection in paired urine and cervical smear samples of HIV-infected women. J Clin Virol 41: 111-115.
18. Louie KS, de Sanjose S, Mayaud P. 2009. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: A comprehensive review. Trop Med Int Health 14: 1287-1302.
19. Manos MM, Ting Y, Wright Dk, Lewis AJ, Briker TR, Wolinsky SM. 1989. The use of polymerase chain reaction amplifications for the detection of genital human papillomaviruses. Cancer Cell 7: 209-214.
20. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL, Canadian Cervical Cancer Screening Trial Study Group. 2007. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357: 1579-1588.
21. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright TC, Jr., Kinney W, Meijer CJ, Linder J, McGoogan E, Meijer C. 2004. Cervical cancer control, priorities and new directions. Int J Cancer 108: 329-333.
22. Payan C, Ducancelle A, Aboubaker MH, Caer J, Tapia M, Chauvin A, Peyronnet D, Le Hen E, Arab Z, Legrand MC, Tran A, Postec E, Tourmen F, Avenel M, Malbois C, De Brux MA, Descamps P, Lunel F. 2007. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and Light Cycler general real-time PCR systems. J Clin Microbiol 45: 897-901.
23. Petignat P, Vassilakos P. 2012. Is it time to introduce HPV self-sampling for primary cervical cancer screening? J Natl Cancer Inst 104: 166-167.
24. Prusty BK, Kumar A, Arora R, Batra S, Das BC. 2005. Human papillomavirus (HPV) DNA detection in self-collected urine. Int Gynecol Obstet 90: 223-227.
25. Puranen M, Saarikoski S, Syrjänen K, Syrjänen S. 1996. Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears. Acta Cytol 40: 391-395.
26. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N, New Technologies for Cervical Cancer Screening Working Group. 2008. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 100: 492-501.
27. Safaeian M, Solomon D, Castle PE. 2007. Cervical cancer prevention-cervical screening: Science in evolution. Obstet Gynecol Clin North Am 34: 739-760.
28. Sasieni P, Adams J. 1999. Effect of screening on cervical cancer mortality in England and Wales: Analysis of trends with an age period cohort model. BMJ 318: 1244-1245.
29. Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V. 2009. Urine HPV-DNA detection for cervical cancer screening: Prospects and prejudices. J Obstet Gynaecol 29: 583-589.
30. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chernesky M. 2000. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Can Med Assoc J 163: 513-518.
31. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr., Young N, Forum Group Members, Bethesda 2001 Workshop. 2002. The 2001 Bethesda System terminology for reporting results of cervical cytology. JAMA 287: 2114-2119.
32. Song ES, Lee HJ, Hwang TS. 2007. Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions. J Korean Med Sci 22: 99-104.
33. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The ClustalX windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acid Res 24: 4876-4882.
34. Vorsters A, Micalessi I, Bilcke J, Ieven M, Pogers J, Van Damme P. 2011. Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis 31: 627-640.
35. Widdice LE, Moscicki AB. 2008. Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents. J Adolesc Health 43: S41-S51.